Pharmaceuticals and Biotech
Regulatory and reimbursement bottlenecks encouraging new business-models
The pharmaceutical industry is in a transformative phase with trends around value-based treatment, personalization and regulatory stringency. Evolving disease patterns towards chronic conditions in emerging markets, and aging population are other drivers for the industry. Companies are focusing more on R&D productivity, virtual clinical trials, and open innovation, while pricing pressures from biosimilars and generics remains a challenge.
Experience across the value chain
Our expertise across the product life cycle right from innovation R&D to Commercialization to life-cycle management will help you get a 360 degree view on future trends, market potential and positioning.
Experience across the value chain
Our expertise across the product life cycle right from innovation R&D to Commercialization to life-cycle management will help you get a 360 degree view on future trends, market potential and positioning.
Select coverage areas
- Clinical trial analytics
- MOA and Target Identification
- Epidemiology
- Indication landscape
- Technology scouting
- Gene therapy services
- Competitive landscape
- Literative analysis
- Evidence generation
Perspectives
Life Sciences
Unmet Needs and Challenges in Personalized Medicin...
Cancer is a complex disease with a high economic burden and requires an effective treatment strategy. This evolving need for effective treatment is addressed by personalized medicine . . .
The content is restricted to premium users only.
Please sign up here to get access to all premium content on the website.
Life Sciences
Aging Population_Impact on Healthcare & Its M...
Rise in aging population is resulting in increased healthcare expenditure, as the elderly are prone to suffer from chronic conditions with acute episodes. The paper delves into the aspects of challenges posed by the health condition of elderly population and its impact . . .
The content is restricted to premium users only.
Pleas...
Life Sciences
Indications Priortization-Inflammation
Leading pharmaceutical client conducted therapeutic area (TA) level analysis in order to select highly attractive inflammation indications . . .
The content is restricted to premium users only.
Please sign up here to get access to all premium content on the website.
Few key questions clients are asking us in the area of Pharmaceuticals and Biotech
What are the different models for value-based treatments in oncology in US?
What are the technologies available for releasing antibiotics through joint replacement implants for 4-8 weeks?
What are strategies and productivity benchmarks of US & EU-5 based small and medium size companies for “virtual clinical trials” ?
How competitors have had overcome the price barriers by applying cost sharing models in the treatment of cancer and diabetes through insulin in ‘out-of-pocket’ geographies ?
What is the market potential and the addressable patient pools for a novel drug in hemophilia A across US and Japan?
Who are the suitable partners in terms of capability, innovation, portfolio, geographic reach etc. for vaccine production?
